Transgenic mouse models in carcinogenesis research and testing

Toxicology Letters

Volumn 112, Issue 113, 2000, Pages 553-555

  Thorgeirsson, Snorri S ^a   Factor, Valentina M ^a   Snyderwine, Elizabeth G ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Liver carcinogenesis; Mice; Transgenics

Indexed keywords

2 AMINO 3,8 DIMETHYLIMIDAZO[4,5 F]QUINOXALINE; GROWTH FACTOR; TRANSFORMING GROWTH FACTOR ALPHA;

ANIMAL MODEL; CARCINOGENESIS; CONFERENCE PAPER; CONTROLLED STUDY; DNA DAMAGE; DRUG RESEARCH; DRUG SCREENING; GENE CONSTRUCT; GENE FUSION; LIVER CARCINOGENESIS; MOUSE; MUTAGENESIS; MUTATION RATE; NONHUMAN; ONCOGENE; ONCOGENE C MYC; PRIORITY JOURNAL; REPORTER GENE; TRANSGENIC MOUSE;

ANIMALS; DISEASE MODELS, ANIMAL; LIVER NEOPLASMS, EXPERIMENTAL; MICE; MICE, TRANSGENIC; PROTO-ONCOGENE PROTEINS C-MYC; RESEARCH; TRANSFORMING GROWTH FACTOR ALPHA;

MUS MUSCULUS;

EID: 0034653446     PISSN: 03784274     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-4274(99)00224-6     Document Type: Article

References (12)

1. Amundadottir L.T., Johnson M.D., Merlino G., Smith G.H., Dickson R.B. Synergistic interaction of transforming growth factor-α and c-myc in mouse mammary and salivary gland tumorigenesis. Cell Growth Differ. 6:1995;737-748.
2. Collins Presnell S., Thompson M.T., Strom S.C. Investigation of the cooperative effects of transforming growth factor-α and c-myc overexpression in rat liver epithelial cells. Mol. Carcinog. 13:1995;233-244.
3. Davis C.D., Dacquel E.J., Schut H.A.J., Thorgeirsson S.S., Snyderwine E.G. In vivo mutagenicity and DNA adduct levels of heterocyclic amines in Muta™ mice and c-myc/lacZ double transgenic mice. Mutat. Res. 356:1996;287-296.
4. Factor V.M., Kiss A., Woitach J.T., Wirth P.J., Thorgeirsson S.S. Disruption of redox homeostasis in the transforming growth factor-alpha/c-myc transgenic mouse model of accelerated hepatocarcinogenesis. J. Biol. Chem. 273:1998;15846-15853.
5. Grisham J.W. Interspecies comparison of liver carcinogenesis: implications for cancer risk assessment. Carcinogenesis. 18:1997;59-81.
6. Lee L.W., Raymond V.W., Tsao M.-S., Lee D.C., Earp H.S., Grisham J.W. Clonal segregation of tumorigenicity with overexpression of c-myc and transforming growth factor-α genes in chemically transformed rat liver epithelial cells. Cancer Res. 51:1991;5238-5244.
7. Lee G.-H., Merlino G., Fausto N. Development of liver tumors in transforming growth factor α transgenic mice. Cancer Res. 52:1992;5162-5170.
8. Murakami H., Sanderson N., Nagy P., Marino P., Merlino G.T., Thorgeirsson S.S. Transgenic mouse model for synergistic effects of nuclear oncogenes and growth factors in tumorigenesis: interaction of c-myc and transforming growth factor α in hepatic oncogenesis. Cancer Res. 53:1993;1719-1723.
9. Sandgren E.P., Luetteke N.C., Qiu T.H., Palmiter R.D., Brinster R.L., Lee D.C. Transforming growth factor alpha dramatically enhances oncogene-induced carcinogenesis in transgenic mouse pancreas and liver. Mol. Cell. Biol. 13:1993;320-330.
10. Santoni-Rugiu E., Nagy P., Jensen M.R., Factor V.M., Thorgeirsson S.S. Evolution of neoplastic development in the liver of transgenic mice co-expressing c-myc and transforming growth factor-α Am. J. Pathol. 149:1996;407-428.
11. Santoni-Rugiu E., Jensen M.R., Thorgeirsson S.S. Disruption of the pRb/E2F pathway and inhibition of apoptosis are major oncogenic events in liver constitutively expressing c-myc and transforming growth factor α Cancer Res. 58:1998;123-134.
12. Sargent L.M., Zhou X., Keck C.L., Sanderson N.D., Zimonjic D.B., Popescu N.C., Thorgeirsson S.S. Nonrandom cytogenetic alterations in hepatocellular carcinoma from transgenic mice overexpressing c-myc and transforming growth factor-α in the liver. Am. J. Pathol. 154:1999;1047-1055.